Clinical Trial Update: Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluated the safety and pharmacokinetics of single ascending doses and multiple ascending doses of CS6253 in healthy volunteers and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CS6253

Snippet

Sponsor: Artery Therapeutics, Inc. | Conditions: Alzheimer's Disease | EARLY_Phase 1 | Status: COMPLETED